Suppr超能文献

链脲佐菌素诱导的糖尿病大鼠巨噬细胞Fc受体功能的改变。

Alterations in Fc receptor function of macrophages from streptozotocin-induced diabetic rats.

作者信息

Abrass C K, Hori M

出版信息

J Immunol. 1984 Sep;133(3):1307-12.

PMID:6235285
Abstract

The presence of elevated levels of circulating immune complexes in diabetic humans and animals suggests impaired phagocyte function. To evaluate FcR-mediated phagocytosis, resident peritoneal macrophages were harvested from control, streptozotocin-induced diabetic, and insulin-treated diabetic rats. FcR number and avidity were determined from Scatchard analysis of binding of 125I-labeled aggregated rat IgG (ARG) to macrophages. The total and fractional catabolic capacity were determined by quantitating the digestion of ARG as a percent of the total ARG added and as a percent of ARG bound. Insulin-deficient diabetic rats had an increase in the number of FcR per cell (26.8 +/- 3.5 X 10(4)) as compared with control animals (13.1 +/- 1.2 X 10(4)) (p less than 0.01). In contrast, insulin-treated diabetic animals had a reduction in the number of FcR per cell (9.8 +/- 1.4 X 10(4)) (p less than 0.01). FcR of macrophages from insulin-deficient diabetic rats had a lower avidity (Kd = 6.9 +/- 1.8 X 10(-10)M) when compared with control (3.7 +/- 0.6 X 10(-10)M) and insulin-treated diabetic rats (3.6 +/- 0.9 X 10(-10)M) (p less than 0.01). Total catabolism of ARG by macrophages from both insulin-deficient and insulin-treated diabetic rats was reduced (31.0% +/- 3.4 and 17.5% +/- 3, respectively) when compared with controls (49.6% +/- 5.2) (p less than 0.01). Fractional catabolism by macrophages from insulin-deficient diabetic rats was significantly reduced (21% +/- 1.9 and 4.6% +/- 0.9/10(4) FcR) when compared with results from control rats (26% +/- 1.3 and 6.7% +/- 0.7/10(4) FcR) (p less than 0.01), whereas the results from insulin-treated diabetic rats (32% +/- 2.4 and 10.8% +/- 1.0/10(4) FcR) (p less than 0.01) were greater than those from controls. These studies demonstrate that FcR-mediated phagocytosis of soluble, "model" immune complexes is impaired in macrophages from both insulin-deficient and insulin-treated diabetic rats; however, different mechanisms account for this impairment in phagocytosis. Despite an increase in FcR number of macrophages from insulin-deficient diabetic rats, the depression of post-receptor-mediated catabolism results in a net depression in phagocytic activity. In contrast, macrophages from insulin-treated diabetic rats display augmented post-receptor-mediated catabolism; however, this does not overcome the low initial binding of ARG to the cell that results from the depression of FcR number.

摘要

糖尿病患者和动物体内循环免疫复合物水平升高表明吞噬细胞功能受损。为评估FcR介导的吞噬作用,从对照大鼠、链脲佐菌素诱导的糖尿病大鼠以及胰岛素治疗的糖尿病大鼠中获取腹腔常驻巨噬细胞。通过对125I标记的聚合大鼠IgG(ARG)与巨噬细胞结合进行Scatchard分析来确定FcR数量和亲和力。通过定量ARG消化量占添加的总ARG量的百分比以及占结合的ARG量的百分比来确定总分解代谢能力和分解代谢分数。与对照动物(13.1±1.2×10⁴)相比,胰岛素缺乏的糖尿病大鼠每细胞FcR数量增加(26.8±3.5×10⁴)(p<0.01)。相反,胰岛素治疗的糖尿病动物每细胞FcR数量减少(9.8±1.4×10⁴)(p<0.01)。与对照(3.7±0.6×10⁻¹⁰M)和胰岛素治疗的糖尿病大鼠(3.6±0.9×10⁻¹⁰M)相比,胰岛素缺乏的糖尿病大鼠巨噬细胞FcR的亲和力较低(Kd = 6.9±1.8×10⁻¹⁰M)(p<0.01)。与对照(49.6%±5.2)相比,胰岛素缺乏和胰岛素治疗的糖尿病大鼠巨噬细胞对ARG的总分解代谢均降低(分别为31.0%±3.4和17.5%±3)(p<0.01)。与对照大鼠的结果(26%±1.3和6.7%±0.7/10⁴FcR)相比,胰岛素缺乏的糖尿病大鼠巨噬细胞的分解代谢分数显著降低(21%±1.9和4.6%±0.9/10⁴FcR)(p<0.01),而胰岛素治疗的糖尿病大鼠的结果(32%±2.4和10.8%±1.0/10⁴FcR)(p<0.01)高于对照。这些研究表明,胰岛素缺乏和胰岛素治疗的糖尿病大鼠巨噬细胞中FcR介导的可溶性“模型”免疫复合物吞噬作用均受损;然而,吞噬作用受损的机制不同。尽管胰岛素缺乏的糖尿病大鼠巨噬细胞FcR数量增加,但受体后介导的分解代谢降低导致吞噬活性净降低。相反,胰岛素治疗的糖尿病大鼠巨噬细胞显示出增强的受体后介导的分解代谢;然而,这并不能克服由于FcR数量降低导致的ARG与细胞的低初始结合。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验